Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Novel Approach to Vertebral Augmentation Procedures

By HospiMedica International staff writers
Posted on 19 Feb 2014
A new implant-based solution for the treatment of vertebral compression fractures (VCFs) represents a departure from balloon kyphoplasty (BKP), the current standard of care.

The Kiva VCF Treatment System is indicated for use in the reduction and treatment of spinal fractures in the thoracic and/or lumbar spine (T6–L5), providing structural support to the vertebral body and a reservoir to direct and contain bone cement during vertebral augmentation. More...
The system features a flexible implant made from PEEK-OPTIMA, a biocompatible polymer that is widely used and well accepted as a spinal implant. The implant is delivered over a removable guidewire in a continuous loop into the vertebral body through a small diameter, single, percutaneous incision. The amount of the Kiva implant delivered is physician-customized during the procedure.

Both right and left systems are available to enable access to the vertebral body from either pedicle, facilitating directional cement delivery and precluding posterior flow. Design features of the system includes a self-contained deployment handle that requires no preparation; and a nitinol coil (guidewire) that allows for controlled placement within the fractured region of the vertebral body and ensures accurate positioning of the Kiva Implant. The radiopaque implant can be adapted to various fracture morphologies. The Kiva System is a product of Benvenue Medical (Santa Clara, CA, USA).

The Kiva VCF Treatment is intended to be used in combination with the Benvenue Vertebral Augmentation cement kit, which contains highly visible polymethyl methacrylate (PMMA) bone cement and an easy-to-use injection system. The vertebral augmentation kit is designed to simplify the mixing and transferring of the PMMA bone cement with minimal exposure to fumes and to provide precise, controlled delivery of the bone cement, thus maximizing working time and facilitating visualization under fluoroscopy.

“We are excited to bring the Kiva System and its clinical benefits to the large and growing population of VCF patients in the US market,” said Robert Weigle, CEO of Benvenue Medical. “The VCF segment has little Level I clinical data, and we are proud to have sponsored one of the largest randomized studies in this space to date.”

Related Links:

Benvenue Medical



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.